Ichiba Mio, Nakamura Masayuki, Sano Akira
Department of Psychiatry, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima 890-8544, Japan.
Brain Nerve. 2008 Jun;60(6):635-41.
Neuroacanthocytosis is an inclusive term for a genetically heterogeneous group of disorders characterized by the association of neurological abnormalities with red cell acanthocytosis. In the late 1960s, Levine et al. reported a family with a syndrome of neurological deficits such as choreiform involuntary movements, epileptic seizures, intellectual impairment, and paranoid ideation along with acanthocytosis without any disturbance in either alpha- or beta-lipoproteins nor retinitis pigmentosa. Critchley et al. also reported familial cases with acanthocytosis and neurological disorders without beta-lipoproteinemia. These cases have been classified as the Levine-Critchley syndrome of neuroacanthocytosis. Cases of neuroacanthocytosis have been classified into 2 groups depending on the presence or absence of movement disorders such as chorea. One group comprises the core neuroacanthocytosis syndromes in which neurodegeneration occurs primarily in the basal ganglia, specifically the striatum, causing movement disorders. The core neuroacanthocytosis syndromes mainly comprise of the two diseases, chorea-acanthocytosis and the McLeod syndrome. Huntington's disease-like 2, and pantothenate kinase-associated neurodegeneration (PKAN) are very rare but these diseases can also be included in this group of syndromes. Advances in molecular genetics have enabled us to distinguish between these diseases. Recently, the hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa and pallidal degeneration syndrome (HARP syndrome) has been genetically shown to be an allelic form of PKAN. The second group of neuroacanthocytosis syndromes includes abetalipoproteinemia (Bassen-Kornzweig disease) and hypobetalipoproteinemia that are characterized by the abnormal decay of lipoprotein with the intestinal malabsorption of fat leading to neurological abnormalities and acanthocytosis. In this type of neuroacanthocytosis shows a progressive spinocerebellar ataxia with peripheral neuropathy and retinitis pigmentosa are observed, but movement disorders are not seen.
神经棘红细胞增多症是一个涵盖多种遗传性疾病的统称,其特征是神经功能异常与红细胞棘形改变同时出现。20世纪60年代末,莱文等人报告了一个家族,该家族患有神经功能缺损综合征,如舞蹈样不自主运动、癫痫发作、智力障碍和偏执观念,同时伴有棘形红细胞增多症,且α或β脂蛋白均无异常,也没有色素性视网膜炎。克里奇利等人也报告了一些家族性病例,这些病例有棘形红细胞增多症和神经疾病,但无β脂蛋白血症。这些病例被归类为莱文 - 克里奇利神经棘红细胞增多症综合征。根据是否存在舞蹈症等运动障碍,神经棘红细胞增多症病例可分为两组。一组包括核心神经棘红细胞增多症综合征,其中神经退行性变主要发生在基底神经节,特别是纹状体,导致运动障碍。核心神经棘红细胞增多症综合征主要包括舞蹈症 - 棘红细胞增多症和麦克劳德综合征这两种疾病。亨廷顿舞蹈病样2型和泛酸激酶相关神经退行性变(PKAN)非常罕见,但这些疾病也可归入这组综合征。分子遗传学的进展使我们能够区分这些疾病。最近,遗传研究表明,低前β脂蛋白血症、棘形红细胞增多症、色素性视网膜炎和苍白球变性综合征(HARP综合征)是PKAN的等位基因形式。神经棘红细胞增多症综合征的第二组包括无β脂蛋白血症(巴森 - 科尔兹韦格病)和低β脂蛋白血症,其特征是脂蛋白异常分解,伴有肠道脂肪吸收不良,导致神经功能异常和棘形红细胞增多症。在这种类型的神经棘红细胞增多症中,可见进行性脊髓小脑共济失调,并伴有周围神经病变和色素性视网膜炎,但未见运动障碍。